These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16822381)
41. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses. Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL; J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622 [TBL] [Abstract][Full Text] [Related]
42. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS; Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135 [TBL] [Abstract][Full Text] [Related]
43. Health literacy and topical corticosteroid adherence in parents of children with atopic dermatitis in France. Halioua B; Taieb C; Clarke J; Ribeyre C; Merhand S; Demessant-Flavigny AL; Seneschal J J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1417-e1419. PubMed ID: 37458523 [No Abstract] [Full Text] [Related]
44. In the management of mild to moderate atopic dermatitis in adults. Recchia M J Drugs Dermatol; 2007 Mar; 6(3):252; author reply 252. PubMed ID: 17373186 [No Abstract] [Full Text] [Related]
45. [Rosacea: pathogenesis, clinical forms and therapy]. Preisz K; Kárpáti S Orv Hetil; 2010 Jul; 151(30):1209-14. PubMed ID: 20650811 [TBL] [Abstract][Full Text] [Related]
46. [Non adherence and topical steroids]. Aubert H; Barbarot S Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S7-12. PubMed ID: 22305285 [TBL] [Abstract][Full Text] [Related]
47. [Angioprotectors in the treatment of rosacea]. Tsiskarishvili NV; Katsitadze A; Tsiskarishvili Ts; Tchitanava L; Tsiskarishvili NI Georgian Med News; 2014 Mar; (228):51-4. PubMed ID: 24743122 [TBL] [Abstract][Full Text] [Related]
48. Spotlight on topical pimecrolimus in pediatric atopic dermatitis. Yang LP; Curran MP Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720 [TBL] [Abstract][Full Text] [Related]
49. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Chu CY Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676 [No Abstract] [Full Text] [Related]
50. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892 [TBL] [Abstract][Full Text] [Related]
51. Topical corticosteroid 'addiction'. A cause of perioral dermatitis. Wells K; Brodell RT Postgrad Med; 1993 Apr; 93(5):225-30. PubMed ID: 8460079 [TBL] [Abstract][Full Text] [Related]
52. Granulomatous Rosacea and Periorificial Dermatitis: Controversies and Review of Management and Treatment. Lee GL; Zirwas MJ Dermatol Clin; 2015 Jul; 33(3):447-55. PubMed ID: 26143424 [TBL] [Abstract][Full Text] [Related]
53. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial. Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960 [TBL] [Abstract][Full Text] [Related]
54. Drugs for acne, rosacea and psoriasis. Treat Guidel Med Lett; 2005 Jul; 3(35):49-56. PubMed ID: 15961971 [No Abstract] [Full Text] [Related]